Dreyfus Andrew 4
4 · Alto Neuroscience, Inc. · Filed Feb 5, 2024
Insider Transaction Report
Form 4
Dreyfus Andrew
Director
Transactions
- Award
Stock Option (right to buy)
2024-02-01+30,574→ 30,574 totalExercise: $16.00Exp: 2034-01-31→ Common Stock (30,574 underlying)
Footnotes (1)
- [F1]The shares underlying the option shall vest in 36 equal monthly installments commencing on March 1, 2024, subject to the Reporting Person's continuous service through each vesting date.